Bachem Holding AG (BANB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
23
About the Report
About the Report
Summary
Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and biotechnology industries. Bachem's research products include biologically active peptides, amino acid derivatives, biochemicals and immunology products. It also provides active pharmaceutical ingredients and custom synthesis. These products and services include peptides indicated for the treatment of various conditions such as central nervous system disorders, metabolic disorders, cancer and infectious diseases, among others; research ingredients; new chemical entities; and generics. The company operates production facilities in the US and Europe. Bachem is headquartered in Bubendorf, Switzerland.
Bachem Holding AG (BANB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Bachem Holding AG, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Bachem Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Magenta Therapeutics Enters into Development and Manufacturing Agreement with Bachem Americas 10
Cyxone Enters into Agreement with Bachem 11
Bachem and Dottikon Enter into Agreement 12
Bachem Enters into Co-Promotion Agreement with Glytech 13
Bachem Expands Co-Marketing Agreement with ILS 14
Acquisition 15
Bachem Americas Acquires American Peptide Company 15
Bachem Holding AG-Key Competitors 16
Bachem Holding AG-Key Employees 17
Bachem Holding AG-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Jul 20, 2018: Bachem: Footprint in Asia 19
Financial Announcements 20
Aug 24, 2018: Bachem-first half of 2018: further rise in the net profit 20
Corporate Communications 21
Oct 26, 2018: Thomas Meier to become new COO of Bachem Group 21
Other Significant Developments 22
Mar 16, 2018: Bachem: Fiscal year 2017-Continued increase in sales, profitability and earnings 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Figure
List of Figures
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Bachem Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Bachem Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Bachem Holding AG, Deals By Therapy Area, 2012 to YTD 2018 8
Bachem Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Magenta Therapeutics Enters into Development and Manufacturing Agreement with Bachem Americas 10
Cyxone Enters into Agreement with Bachem 11
Bachem and Dottikon Enter into Agreement 12
Bachem Enters into Co-Promotion Agreement with Glytech 13
Bachem Expands Co-Marketing Agreement with ILS 14
Bachem Americas Acquires American Peptide Company 15
Bachem Holding AG, Key Competitors 16
Bachem Holding AG, Key Employees 17
Bachem Holding AG, Subsidiaries 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.